Sponsor:
University of Calgary
Code:
NCT04789616
Conditions
Stroke
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Maraviroc
Exercise Program
Placebo
Activity Sensor
Motor Learning
Brief summary:
Conditions
Stroke
Study ID
NCT04789616
Start date
Sep 15, 2022
Status verified date
Jul, 2024
Completion date
Dec, 2025
Anticipated
Primary completion date
Dec, 2025
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
120 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Maraviroc (Celsentri)
placebo comparator: Placebo
Interventions
Maraviroc
Exercise Program
Placebo
Activity Sensor
Motor Learning
Primary outcome measure
Central contacts
Locations
University of Calgary & Foothills Medical Centre
Recruiting
Calgary, Alberta, Canada, T2N 2T9
Contacts
Principal Investigator:
Gentson Leung, MD
University of British Columbia & GF Strong Rehabilitation Centre
Recruiting
Vancouver, British Columbia, Canada, V5Z 2G9
Contacts
Principal Investigator:
Janice Eng, PhD
Dalhousie University
Recruiting
Halifax, Nova Scotia, Canada, B3H 3J5
Contacts
Principal Investigator:
Marilyn Mackay-Lyons, PhD
Parkwood Institute
Recruiting
London, Ontario, Canada, N6C 0A7
Contacts
Shiela Geniblazo
Shiela.Geniblazo@sjhc.london.on.caPrincipal Investigator:
Robert Teasell, MD
Sponsor
University of Calgary
Last update posted
Jul 9, 2024
Last verified
Jul, 2024
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Calgary on 2024-07-09.